Maynard Ryan D
SEC CIK 1363984 · EDGAR
BoughtSold
Most active insiders at IOVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kirby Daniel Gordon | Chief Commercial Off | — | — |
| 2 | Puri Raj K. | Chief Regulatory Off | — | — |
| 3 | Roche Corleen M. | CFO | — | — |
| 4 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Off | — | — |
| 5 | Vogt Frederick G | GC, Interim CEO, Dir | — | — |
| 6 | BILINSKY IGOR | COO | — | — |
Maynard Ryan D made no open-market trades at IOVA in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | 2024-11-12 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Maynard Ryan D | Dir | S - Sale+OE | $10.06 | -50.0K | 7,500 | -87% | -$503.0K |
| D | 2024-11-14 | 2024-11-12 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Maynard Ryan D | Dir | M - OptEx | $7.45 | +50.0K | 57.5K | +667% | +$372.5K |
| 2024-02-12 | 2023-02-08 | TVRD | Tvardi Therapeutics, Inc. | Maynard Ryan D | CFO | S - Sale | $0.53 | -5,488 | 8,012 | -41% | -$2,909 | |
| 2024-02-05 | 2024-02-01 | TVRD | Tvardi Therapeutics, Inc. | Maynard Ryan D | CFO | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 | |
| 2022-06-02 | 2022-05-31 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Maynard Ryan D | Dir | P - Purchase | $6.75 | +7,500 | 7,500 | New | +$50.6K |
Purchase Sale Sale after option exercise All abbreviations